Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_assertion type Assertion NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_head.
- NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_assertion description "[Compared with double noncarriers (angiotensinogen -20aa and ACE II), double heterozygotes (ac-I/D genotype), and double homozygotes (cc-DD) had hazard ratios for atrial fibrillation of 1.2(0.9-1.6; P=0.06) and 2.4(1.4-4.1; P=0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_provenance.
- NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_assertion evidence source_evidence_literature NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_provenance.
- NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_assertion SIO_000772 18496132 NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_provenance.
- NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_assertion wasDerivedFrom befree-20150227 NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_provenance.
- NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_assertion wasGeneratedBy ECO_0000203 NP934880.RAlMLzQhnl7V_FsqO3n0XOpsyXixvuFofCLHPbC-IKDhI130_provenance.